Skip to content

Clinical study on the changes in the vascular endothelial function by the intervention for hypertriglyceridemia in patients with type 2 diabetes treated with statin.

Clinical study on the changes in the vascular endothelial function by the intervention for hypertriglyceridemia in patients with type 2 diabetes treated with statin. - Interventional study on type2 diabetes with hypertriglyceridemia.

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000016676
Enrollment
50
Registered
2015-03-03
Start date
2015-01-14
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Type 2 diabetes patients with hypertriglyceridemia

Interventions

The continued treatment with statin, and cookies meal test is performed to evaluate postprandial hypertriglyceridemia. It&#39
s changed to treatment with ezetimib/fenofibrate from treatment with statin, and cookies meal test performed to evaluate postprandial hypertriglyceridemia.

Sponsors

Kagoshima University Graduate School of Medical and Dental Sciences
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: LDL <=120 mg/dl TG >=120 mg/dl HbA1c <=8.0%

Exclusion criteria

Exclusion criteria: HbA1c > 8.0%. Patients with severe liver dysfunction. Patients with history of hypersensitivity to study drugs. Serum creatinine >= 2.5 mg/dl. Patients with secondary properties and drug-induced lipid abnormalities. Patients with familial hypercholesterolemia. Pregnancy example. Patients with history of coronary artery disease.

Design outcomes

Primary

MeasureTime frame
We compare the lipoprotein profile and FMD(flow mediated dilation) between the two groups(Statin group and Ezetimibe/fenofibrate combination group). we compare also changes in postprandial hypertriglyceridemia.

Secondary

MeasureTime frame
Before and after Cookies meal test, relation between lipid parameters(total cholesterol, triglycerides, HDL, LDL, LPL, apoprotein) and FMD.

Countries

Japan

Contacts

Public ContactAtsushi Shinnakasu

Kagoshima University Graduate School of Medical and Dental Sciences Department of Diabetes and Endocrinology

atushi312@yahoo.co.jp099-275-6478

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026